A new approach combining interferon and bromocriptine LA to prevent spontaneous mouse mammary carcinoma.
The development of spontaneous mammary carcinoma in C3H mice is mainly attributed to an oncogenic virus (MMTV) and the high prolactin levels of this inbred strain. Interferon (IFN) reduces the incidence of mammary carcinoma in virgin C3H mice when administered during lactation. Bromocriptine LA, an antiprolactin drug, also decreases the incidence of this tumor in C3H mice. The combined action of mouse IFN-alpha + beta and bromocriptine LA had a significant anticarcinogenic effect more significant than either of the above agents administered independently. This antitumor action was effective in virgin C3H mice only.
Stravoravdi
P
P
Theagenion Cancer Hospital, Thessaloniki, Greece.
Toliou
T
T
Polyzonis
M B
MB
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001971:Bromocriptine / Q000008:administration & dosage; D003692:Delayed-Action Preparations; D005260:Female; D007372:Interferons / Q000008:administration & dosage; D008325:Mammary Neoplasms, Experimental / Q000235:genetics / Q000517:prevention & control*; D051379:Mice; D008809:Mice, Inbred C3H
D003692:Delayed-Action Preparations; D001971:Bromocriptine; D007372:Interferons